Galvanize Therapeutics is a startup, most recent round Series-c-plus, 1 tracked investor.
Galvanize Therapeutics is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Develops the Aliya® pulsed electric field (PEF) ablation system, a medical device intended to treat cancer and chronic lung disease; the company has run clinical trials evaluating the system for late-stage non-small cell lung cancer and lung metastases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.